SHR # 2505 :: Nicotinamide May Treat Fibrotic Eye Diseases and Mitigate Vision Loss - Dr. Tim Blenkinsop, PhD - Most diseases that cause catastrophic loss of vision do so as a result of abnormal angiogenesis and wound healing. This may be a result of injury, aging or diabetes. New research indicates that the use of a common and inexpensive vitamin B3, nicotinamide, not only inhibits these cell transformations, but can also reverse that cell transition and slow down the development of eye diseases that may lead to vision loss or blindness. Most fascinating is that these advanced nutrient therapies may prove to effect all tissue types throughout the entire body.